Results 11 to 20 of about 9,205 (230)

Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors? [PDF]

open access: yesJournal of Pharmacy and Bioallied Sciences, 2011
Increased risk of coronary artery disease in diabetic persons is associated with increased level of lipoproteins. Usually, such risks are reverted with glycemic control by antidiabetic medicines in Type I diabetes millitus.
Afshan Siddiq   +2 more
doaj   +2 more sources

Biguanides enhance antifungal activity against Candida glabrata [PDF]

open access: yesVirulence, 2018
Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge.
Shuying Xu   +13 more
doaj   +2 more sources

Biguanides in combination with olaparib limits tumorigenesis of drug‐resistant ovarian cancer cells through inhibition of Snail [PDF]

open access: yesCancer Medicine, 2020
Ovarian cancer is the most lethal gynecological malignancy. Currently, new chemotherapeutic strategies are required to improve patient outcome and survival.
Qiong Wang   +8 more
doaj   +2 more sources

Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway [PDF]

open access: yesCell Reports Medicine
Summary: The biguanide metformin attenuates mitochondrial oxidation and is proposed as an anti-cancer therapy. However, recent clinical studies suggest increased proliferation and fatty acid β-oxidation (FAO) in a subgroup of patients with breast cancer (
Jun Hyoung Park   +25 more
doaj   +3 more sources

Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study [PDF]

open access: yesActa Pharmaceutica, 2018
Extensive in vitro studies have been conducted to evaluate the anticancer activity of oral hypoglycemic agents. Many of these studies experienced detrimental limitations, since they were conducted on cancer cells commonly grown in culture media ...
Bardaweel Sanaa K.   +3 more
doaj   +5 more sources

Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients. [PDF]

open access: yesPLoS ONE
BackgroundWestern guidelines often recommend biguanides as the first-line treatment for diabetes. However, dipeptidyl peptidase-4 (DPP-4) inhibitors, alongside biguanides, are increasingly used as the first-line therapy for type 2 diabetes (T2DM) in ...
Eiji Nakatani   +14 more
doaj   +2 more sources

Antidiabetic Biguanides as Anti-Aging Drugs [PDF]

open access: yes, 2020
Evidence has emerged that metformin and other antidiabetic biguabides are promising candidates for pharmacological interventions leading to slowing down of aging, prolonged life span and preventing or postponing age-associate diseases, including cancer ...
Anisimov V.N.
core   +3 more sources

Biguanides, anion receptors and sensors [PDF]

open access: yes, 2017
Biguanides are strong bases (pKa > 10), their protonated forms bind anions and may therefore act as receptors for anions.
Mariia Pushina, Pavel Anzenbacher
core   +1 more source

Towards Elucidating the Mechanism of Action of Biguanides [PDF]

open access: yes, 2018
Diabetes type 2 patients are insensitive to insulin, a condition that leads to reduced glucose uptake by cells and, subsequently, to high concentration of glucose in the blood.
Goeldel, Nicolas Peter
core   +1 more source

Activity of Certain Aryl-Substituted Biguanides as Accelerators of Vulcanization [PDF]

open access: yes, 1928
Aryl-substituted biguanides are rubber vulcanization accelerators of moderate activity. The relation between the chemical constitution of the substituted radicals and the activity of the biguanides is, in general, about the same as found by other ...
G. B. L. Smith, A. J. Weiss
core   +1 more source

Home - About - Disclaimer - Privacy